Talk to Princeton Postdoctoral Research Fellow Tom J. Zajdel long enough, and the egalitarian streak comes out.
NJ ACTS Highlights
NJ ACTS is pleased to announce a clinical and translational science fellowship opportunity for graduate students and postdoctoral trainees.
Please visit the Training Awards page to review the program overview and Request for Applications, and to access the Application due...
Spurred by the COVID-19 pandemic, Princeton researchers have developed a diagnostic tool to analyze chest X-rays for patterns in diseased lungs.
Read about the Rutgers Health Care Worker Corona Cohort Study, Princeton's efforts to design simplified ventilators and NJIT's pathogen resistant PPE.
In what could represent a major advance in the fight against coronavirus, a Rutgers University research lab says it has developed a new test using existing automated technology able to analyze tens of thousands of patient samples each day to detect COVID-19.
The NJ ACTS Biostatistics, Epidemiology and Research Design (BERD) Core is pleased to announce a call for applications for the Year 2 BERD Mini-Methods Grants Program.
The NJ ACTS 2020 Pilot Grants Program is supported by a grant from the National Institutes of Health/National Center for Advancing Translational Sciences, as well as funds from the New Jersey Health Foundation.
There are 5 categories for potential pilot projects with awards up to $110,000 available.
NJ ACTS is excited to announce the awardees of the 2019 Partnership and Innovation Accelerator Pilot Grant Program (PIAP), Usha Ramachandran, MD and Helmut Zarbl, PhD. Continue to read full...
New Jersey residents will have access to the newest clinical trials and medical breakthroughs as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology.
A team led by the Rutgers Institute for Translational Medicine and Science that includes Princeton University and the New Jersey Institute of Technology has received a National Institutes of Health grant for $29 million over five years for joining the NIH's Clinical and Translational Science Awards Program (CTSA).